Halladay Benjamin plan to sell securities of Esperion Therapeutics, Inc. under Form 144

Halladay Benjamin filed Form 144 to notify SEC of plan to sell 10773 units of Esperion Therapeutics, Inc. securities around 2026-06-17, with aggregate market value of $33,985.59. The total outstanding units is 257431942.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months include: On 03/17/2026, sold 6424 units for $17374.98;